Validation of a Model to Identify Young Patients for Lymph Node Biopsy

G. B. Slap, J. L. Conor, Robert Swift Wigton, J. S. Schwartz

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A model to identify 9- to 25-year-old patients with malignant or granulomatous lymphadenopathy demonstrated a sensitivity/specificity of 0.95/0.96 in the original sample. This study tests the performance of the model in three new samples (n=34, 87, 46) of young patients with peripheral lymphadenopathy. Patient charts were reviewed for the biopsy diagnosis and for the three variables in the model (lymph node size, recent ear-nose-throat symptoms, and chest roentgenogram). Prevalence rates of malignancy or granuloma in the three samples were 0.71, 0.37, and 0.37. The model's sensitivity/specificity in the three samples were 0.96/1.00, 0.88/0.80, and 0.82/0.83. Receiver operating characteristic curve areas for the model ranged from 0.87 to 0.98, indicating excellent discrimination. Likelihood ratios were calculated for all scores to allow adjustment of the model's predictions for population differences in the prevalence of malignancy or granuloma. We conclude that the model performs well and can help physicians to select those young patients with peripheral lymphadenopathy who should undergo biopsy.

Original languageEnglish (US)
Pages (from-to)2768-2773
Number of pages6
JournalJAMA: The Journal of the American Medical Association
Volume255
Issue number20
DOIs
StatePublished - May 23 1986

Fingerprint

Lymph Nodes
Biopsy
Granuloma
Sensitivity and Specificity
Pharynx
Nose
ROC Curve
Ear
Neoplasms
Thorax
Physicians
Population
Lymphadenopathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Validation of a Model to Identify Young Patients for Lymph Node Biopsy. / Slap, G. B.; Conor, J. L.; Wigton, Robert Swift; Schwartz, J. S.

In: JAMA: The Journal of the American Medical Association, Vol. 255, No. 20, 23.05.1986, p. 2768-2773.

Research output: Contribution to journalArticle

@article{5e6a3898928e4bfea9f3ca29e4389e91,
title = "Validation of a Model to Identify Young Patients for Lymph Node Biopsy",
abstract = "A model to identify 9- to 25-year-old patients with malignant or granulomatous lymphadenopathy demonstrated a sensitivity/specificity of 0.95/0.96 in the original sample. This study tests the performance of the model in three new samples (n=34, 87, 46) of young patients with peripheral lymphadenopathy. Patient charts were reviewed for the biopsy diagnosis and for the three variables in the model (lymph node size, recent ear-nose-throat symptoms, and chest roentgenogram). Prevalence rates of malignancy or granuloma in the three samples were 0.71, 0.37, and 0.37. The model's sensitivity/specificity in the three samples were 0.96/1.00, 0.88/0.80, and 0.82/0.83. Receiver operating characteristic curve areas for the model ranged from 0.87 to 0.98, indicating excellent discrimination. Likelihood ratios were calculated for all scores to allow adjustment of the model's predictions for population differences in the prevalence of malignancy or granuloma. We conclude that the model performs well and can help physicians to select those young patients with peripheral lymphadenopathy who should undergo biopsy.",
author = "Slap, {G. B.} and Conor, {J. L.} and Wigton, {Robert Swift} and Schwartz, {J. S.}",
year = "1986",
month = "5",
day = "23",
doi = "10.1001/jama.1986.03370200070030",
language = "English (US)",
volume = "255",
pages = "2768--2773",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "20",

}

TY - JOUR

T1 - Validation of a Model to Identify Young Patients for Lymph Node Biopsy

AU - Slap, G. B.

AU - Conor, J. L.

AU - Wigton, Robert Swift

AU - Schwartz, J. S.

PY - 1986/5/23

Y1 - 1986/5/23

N2 - A model to identify 9- to 25-year-old patients with malignant or granulomatous lymphadenopathy demonstrated a sensitivity/specificity of 0.95/0.96 in the original sample. This study tests the performance of the model in three new samples (n=34, 87, 46) of young patients with peripheral lymphadenopathy. Patient charts were reviewed for the biopsy diagnosis and for the three variables in the model (lymph node size, recent ear-nose-throat symptoms, and chest roentgenogram). Prevalence rates of malignancy or granuloma in the three samples were 0.71, 0.37, and 0.37. The model's sensitivity/specificity in the three samples were 0.96/1.00, 0.88/0.80, and 0.82/0.83. Receiver operating characteristic curve areas for the model ranged from 0.87 to 0.98, indicating excellent discrimination. Likelihood ratios were calculated for all scores to allow adjustment of the model's predictions for population differences in the prevalence of malignancy or granuloma. We conclude that the model performs well and can help physicians to select those young patients with peripheral lymphadenopathy who should undergo biopsy.

AB - A model to identify 9- to 25-year-old patients with malignant or granulomatous lymphadenopathy demonstrated a sensitivity/specificity of 0.95/0.96 in the original sample. This study tests the performance of the model in three new samples (n=34, 87, 46) of young patients with peripheral lymphadenopathy. Patient charts were reviewed for the biopsy diagnosis and for the three variables in the model (lymph node size, recent ear-nose-throat symptoms, and chest roentgenogram). Prevalence rates of malignancy or granuloma in the three samples were 0.71, 0.37, and 0.37. The model's sensitivity/specificity in the three samples were 0.96/1.00, 0.88/0.80, and 0.82/0.83. Receiver operating characteristic curve areas for the model ranged from 0.87 to 0.98, indicating excellent discrimination. Likelihood ratios were calculated for all scores to allow adjustment of the model's predictions for population differences in the prevalence of malignancy or granuloma. We conclude that the model performs well and can help physicians to select those young patients with peripheral lymphadenopathy who should undergo biopsy.

UR - http://www.scopus.com/inward/record.url?scp=0022634804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022634804&partnerID=8YFLogxK

U2 - 10.1001/jama.1986.03370200070030

DO - 10.1001/jama.1986.03370200070030

M3 - Article

C2 - 3701990

AN - SCOPUS:0022634804

VL - 255

SP - 2768

EP - 2773

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 20

ER -